Ovagen (Ovagen (Liver & GI Peptide Bioregulator))
A short peptide bioregulator from the Khavinson family associated with liver and gastrointestinal tissue. It is used in the bioregulator community for liver function, protein synthesis support, and gut/immune resilience.
How it works
As a signal peptide, it is proposed to regulate gene expression in hepatic and gastrointestinal tissue, supporting protein synthesis, detoxification pathways, and gut-associated immune function.
Key facts
- Molecular weight: ~ (short peptide)
- Half-life: Short (peptide)
- Bioavailability: Oral (encapsulated) or subcutaneous
- Storage: Room temperature (capsules) or refrigerate (injectable).
Dosing overview
- Typical dose: ~1-2 capsules/day or short injectable courses
- Frequency: Once daily
- Duration: 10-30 day courses
- Route: Oral capsule or subcutaneous
Protocol notes
- Taken as short repeatable courses (often 10-30 days), a few times per year.
- Oral encapsulated forms are taken once daily on an empty stomach.
- Frequently used alongside gut-healing peptides in bioregulator protocols.
Reported benefits
- Liver function support
- Gastrointestinal tissue support
- Protein synthesis support (proposed)
- Gut-immune resilience
- Short course-based protocol
Possible side effects
- Limited Western clinical data
- Injection site reactions (injectable)
- Unknown long-term effects
Research
- Hepatic and GI peptide bioregulators (2016): Reported to support liver protein synthesis and gastrointestinal tissue function in regional research studies.
Compare Ovagen
Research and educational reference only. Not medical advice.